GBA1 and Parkinson disease: Homozygous and heterozygous GBA mutations confer an important and increasing risk of developing PD; that is, heterozygous carriers present a cumulative risk of developing PD of approximately 5% at age 60 years, which increased to 15–30% at age 80 years [31,32,33].